Ginkgo Biloba Extract

NootropiccognitiveModerate dose evidence

Also known as: Ginkgo biloba leaf extract, EGb 761, maidenhair tree, ginkgo 24/6

Add to a formula

A leaf extract from the ginkgo tree standardized to flavone glycosides and terpene lactones, long used in memory and circulation formulas. The strongest evidence comes from trials of the EGb 761 extract at 240 mg per day in older adults with cognitive impairment; findings in healthy younger adults are mixed. It remains one of the most recognizable cognitive botanicals and is often included at lower amounts in multi-ingredient nootropic blends.

Research summary

Flavone glycosides and terpene lactones are thought to improve microcirculation, inhibit platelet-activating factor, and provide antioxidant activity in neural tissue.

Dosage

Daily amounts, of extract.

Lowest studiedTypical rangeHighest studiedUpper limit
120 mg120–240 mg240 mg

120 to 240 mg per day of a 24/6 extract, usually split into two doses with meals. Trials in cognitive impairment ran 22 to 26 weeks before benefits were assessed. Stop use before surgery because of antiplatelet effects.

Standardization: 24% flavone glycosides, 6% terpene lactones

Source material: leaf extract

Format suitability

  • Capsule
  • Powder
  • Tablet
  • Softgel
  • Gummy
  • Liquid

Bitter; small dose size keeps capsule counts low.

Formulation notes

Notable interaction potential with anticoagulant and antiplatelet drugs. Often combined with bacopa or phosphatidylserine. Watch for adulteration with cheap flavonoid spikes; request a full 24/6 profile.

  • Notable drug interactions

Sources

  1. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis. (Tan 2015)PubMed
  2. Ginkgo Biloba — ExamineExamine

Related ingredients